Final OK Granted for US Gold-Antimony Project
Research Report
Pharma Innovator Reveals Groundbreaking Diabetes Treatment
Research Report
Biotech Advances Breakthrough Cancer Treatment Results
Research Report
US Co. Granted Mining Project Permit After 8-Year Process
Research Report
Oil and Gas Exploration Co. Released Better-Than-Expected Production Results
Research Report
Exploration and Development Co. Hits High-Grade Silver
Research Report
Energy Co. Resumes Production of Triton Asset
Research Report
Oil and Gas Exploration Co. Reports Positive Drill Results
Research Report
Sintana Energy Inc. (SEI:TSX.V; SEUSF:OTCQX) recently reported positive drilling results at its Mopane-2A well, which encountered gas condensate and a new light oil reservoir, noted an Auctus Advisors research note. Mining Co. Secures Premium Funding for Michigan Helium Project
Research Report
Pulsar Helium Inc. (PLSR:TSX.V) recently reported a new equity raise at a premium to market price, according to an Auctus Advisors research note. Pharma Innovator Unlocks Multi-Disease Treatment Potential
Research Report
Quince Therapeutics Inc. is "positioned for a transformative year" in 2025 with a solid cash position of US$47.8 million as of the third quarter of 2024. Find out why one analyst gives the stock a Buy rating. Drug Innovator Launches Pivotal Cancer Trial Breakthrough
Research Report
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) has the potential to generate hundreds of millions of dollars over the next decade with its drug candidates, an H.C. Wainwright & Co. analyst wrote in a January 2 research note. Miami Biopharma Sells Part of Business and Begins New Clinical Trial
Research Report
Miami biopharmaceutical company Veru Inc. (VERU:NASDAQ) recently sold its FC2 Female Condom business for US$18 million, and has begun enrolling patients for its The Phase 2b QUALITY trial of enobosarm in combination with Wegovy (semaglutide) for sarcopenic obesity. Read on to see why one analyst gives this company a Buy rating. Analyst Sees Major Growth for Biopharma With Weight-Loss Drug
Research Report
Recent successes of weight-loss drugs like Ozempic and Wegovy have led H.C. Wainwright & Co. Analyst Ed Arce to be "intrigued" by MetaVia Inc.'s (MTVA:NASDAQ) new drug candidate. Analyst Initiates Coverage of Co. With 'Once-in-a-Generation' Drug
Research Report
NewAmsterdam Pharma Company N.V.'s (NAMS:NASDAQ) drug obicetrapib is a "once-in-a-generation" drug for cardiovascular disease, an analyst wrote in a research note while initiating coverage on the company. See what rating the stock got and its price per share target. New Metallurgical Findings Would Boost Project NAV
Research Report
Improved metals recoveries make the economics of this three-deposit, polymetallic project in Spain compelling, noted a Clarus Securities report. Gold Co. Embarks on Phase III Drilling Program
Research Report
Nevada King Gold Corp. (NKGFF:OTCMKTS; NKG:TSX) recently started its Phase III drilling program at its Atlanta Gold Project, according to a Roth MKM research note. 
Streetwise Key Charts
